Groessmann, N (2020): Isatuximab (Sarclisa®) plus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (MM). Oncology Fact Sheet Nr. 6.

Robausch, M and Groessmann, N (2020): Health Services Research in Oncology. Part I: End-of-Life Care . HTA-Projektbericht 127.

Groessmann, N (2020): Brentuximab vedotin (Adcetris®) with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCL). Oncology Fact Sheet Nr. 5.